Recorded Date: Thursday, January 7, 2021
Program Number: 21EL-601

Educational Track: Technical/Clinical
Intended Audience: COOs, Directors, Donor Recruitment Staff, Hospital Blood Banks, Hospitals, Laboratory Staff, Managers/Supervisors, Medical Directors, Nurses, Residents/Fellows, Students (MD, MT, SBB), Technologists, Transfusion Safety Officers
Teaching Level: Basic, Intermediate

Faculty
(affiliations at the time of the live program)
Moderator: Sharon Carayiannis, BSMT(ASCP)HP, Senior Director, Regulatory Affairs, AABB
Speakers:

Jed B. Gorlin, MD, MBA, Innovative Blood Resources
Brian Custer, PhD, MPH, Vitalant Research Institute
Peter Marks, MD, PhD, Food & Drug Administration

Program Description
Join us for an exciting discussion addressing key donor eligibility considerations as we head into 2021. First Dr. Jed Gorlin will outline considerations and strategies around the impact of COVID-19 vaccines on blood donation, including convalescent plasma donors. Then Dr. Brian Custer will provide a summary and next step for practices around HIV detection in the ART/PrEP era. Finally, Dr. Peter Marks will provide an update on the agency’s MSM deferral policies and current studies. Presentations will be followed by an engaging Q&A period where speakers will field questions from the audience.

Learning Objectives
After participating in this educational activity, participants should be able to:

Consider the impact of COVID-19 vaccines on blood donation and options for updating donor deferral policies.
Discuss the latest research on the impact of ART and PrEP on HIV detection in blood donors and donor deferrals.
Discuss the FDA’s approach to MSM donor deferrals and future studies to inform policy decisions.

This program is complimentary to AABB members.

How to Claim CE Credit
Complete the evaluation found on the "CE Information" tab after watching the video. By submitting the evaluation, you are attesting to watching the presentation in its entirety.

Sharon Carayiannis MT(ASCP)HP

Vice President, Accreditation, Standards & Quality, AABB

Appearances